BSE Live
Feb 06, 16:01Prev. Close
1255.00
Open Price
1255.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Feb 06, 15:50Prev. Close
1259.40
Open Price
1259.40
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of HALEOS LABS (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 3.02 | 3.02 | 3.02 | 3.02 | 3.02 | |
| Total Share Capital | 3.02 | 3.02 | 3.02 | 3.02 | 3.02 | |
| Reserves and Surplus | 194.15 | 173.20 | 161.00 | 148.19 | 123.31 | |
| Total Reserves and Surplus | 194.15 | 173.20 | 161.00 | 148.19 | 123.31 | |
| Total Shareholders Funds | 197.18 | 176.23 | 164.03 | 151.21 | 126.34 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 17.31 | 28.31 | 45.97 | 26.85 | 21.63 | |
| Deferred Tax Liabilities [Net] | 13.59 | 13.72 | 11.90 | 9.87 | 9.86 | |
| Other Long Term Liabilities | 1.74 | 2.39 | 1.30 | 1.85 | 6.48 | |
| Long Term Provisions | 4.20 | 4.02 | 3.62 | 3.25 | 2.93 | |
| Total Non-Current Liabilities | 36.84 | 48.45 | 62.80 | 41.83 | 40.89 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 61.86 | 60.41 | 39.17 | 32.89 | 20.20 | |
| Trade Payables | 45.99 | 49.54 | 54.53 | 70.85 | 56.34 | |
| Other Current Liabilities | 14.85 | 11.11 | 15.58 | 14.25 | 27.16 | |
| Short Term Provisions | 1.59 | 1.64 | 1.28 | 0.97 | 0.82 | |
| Total Current Liabilities | 124.30 | 122.70 | 110.57 | 118.96 | 104.51 | |
| Total Capital And Liabilities | 358.31 | 347.38 | 337.39 | 312.00 | 271.74 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 150.19 | 138.19 | 139.54 | 98.61 | 100.69 | |
| Intangible Assets | 0.04 | 0.04 | 0.08 | 0.11 | 0.14 | |
| Capital Work-In-Progress | 0.40 | 6.00 | 0.85 | 21.21 | 3.16 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 150.63 | 144.23 | 140.47 | 119.93 | 103.99 | |
| Non-Current Investments | 23.23 | 23.23 | 23.23 | 23.24 | 25.81 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 6.66 | 5.42 | 6.10 | 6.52 | 6.52 | |
| Total Non-Current Assets | 180.52 | 172.88 | 169.80 | 149.68 | 136.32 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 60.58 | 74.59 | 80.46 | 81.36 | 58.76 | |
| Trade Receivables | 64.53 | 49.35 | 45.52 | 33.77 | 29.99 | |
| Cash And Cash Equivalents | 1.41 | 1.26 | 0.95 | 2.14 | 8.90 | |
| Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| OtherCurrentAssets | 51.27 | 49.30 | 40.66 | 45.05 | 37.77 | |
| Total Current Assets | 177.79 | 174.49 | 167.59 | 162.32 | 135.43 | |
| Total Assets | 358.31 | 347.38 | 337.39 | 312.00 | 271.74 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 68.58 | 50.84 | 61.38 | 80.77 | 69.79 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 47.41 | 55.63 | 72.01 | 73.06 | 42.94 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.28 | 0.83 | 0.40 | 0.99 | 0.65 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 126.03 | 122.43 | 99.75 | 128.34 | 80.41 | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 23.23 | 23.23 | 23.23 | 23.24 | 25.81 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
17.11.2025
SMS Lifescience Consolidated September 2025 Net Sales at Rs 81.37 crore, up 3.7% Y-o-Y
12.11.2025
SMS Lifescience Standalone September 2025 Net Sales at Rs 77.84 crore, down 0.83% Y-o-Y
08.09.2025
SMS Lifescience Standalone June 2025 Net Sales at Rs 79.04 crore, down 8.7% Y-o-Y
12.06.2025
SMS Lifescience Standalone March 2025 Net Sales at Rs 85.43 crore, down 1.1% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017